| Title: | The NMR-measured omega-6/omega-3 fatty acid ratio improves cardiovascular risk prediction |
| Journal: | Frontiers in Nutrition |
| Published: | 29 Oct 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/41235302/ |
| DOI: | https://doi.org/10.3389/fnut.2025.1693151 |
| URL: | https://public-pages-files-2025.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1693151/pdf |
Publication 16623
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Background: Improving 10-year cardiovascular risk prediction beyond the established SCORE2 algorithm is a clinical need. The plasma omega-6/omega-3 (O6:O3) polyunsaturated fatty acid (PUFA) ratio, a marker of inflammatory balance, is a promising biomarker for enhancing risk stratification. We aimed to evaluate if adding the O6:O3 ratio to the SCORE2 model improves the prediction of major adverse cardiovascular events (MACE).</p>
Methods: We conducted a prospective cohort study of 183,230 UK Biobank participants (aged 50-69 years, free of baseline cardiovascular disease or diabetes). The plasma O6:O3 ratio was measured by nuclear magnetic resonance (NMR) spectroscopy. We compared the predictive performance of the SCORE2 model with and without the O6:O3 ratio in an independent validation cohort (N = 54,940) using Harrell's C-index, Net Reclassification Improvement (NRI), and Integrated Discrimination Improvement (IDI).</p>
Results: In the validation set, adding the O6:O3 ratio to SCORE2 significantly increased the C-index from 0.742 (95% CI: 0.738-0.746) to 0.747 (95% CI: 0.743-0.751) (p < 0.001). The extended model also significantly improved risk reclassification (NRI 8.4, 95% CI: 3.6-12.2%; IDI 0.021, 95% CI: 0.010-0.032). This improvement was more pronounced in men than in women, and both models remained well-calibrated.</p>
Conclusion: Incorporating the plasma O6:O3 PUFA ratio provides a modest but statistically significant improvement in 10-year MACE risk prediction with the SCORE2 algorithm. As a modifiable biomarker, the O6:O3 ratio holds potential to refine risk stratification and guide personalized nutritional interventions.</p>
8 Authors
- Youwei Huang
- Xianzhou Lu
- Yanyan Shen
- Ying Liu
- Qiqing Zeng
- Xianrong Liu
- Wenkai Bin
- Meili Li
Enabling scientific discoveries that improve human health